Piramal Pharma Limited — Important, 22-07-2025: Sale or disposal

Piramal Pharma (PPL) has updated on the sale of its decommissioned Thane unit. The previous Memorandum of Understanding for this unit was terminated. PPL's Administrative Committee has now approved a new sale deed with Global Pharma for approx. Rs. 8.50 Cr plus taxes. This transaction is anticipated to conclude within 90 days. PPL emphasizes this unit contributed nil to last year's financials, ensuring the sale will not impact current company operations. This move helps monetize a non-operational asset.